Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: BROVANA

« Back to Dashboard

Summary for Tradename: BROVANA

Patents:13
Applicants:1
NDAs:1
Suppliers: see list1

Pharmacology for Tradename: BROVANA

Clinical Trials for: BROVANA

Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
Status: Completed Condition: COPD

A Dose Ranging Study of Arformoterol Given Once Daily Compared to Arformoterol Given Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Status: Completed Condition: COPD

A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients
Status: Terminated Condition: Acute Asthma

Perforomist Versus Foradil Evaluated by Inspiratory Capacity and High Resolution Computed Tomography (HRCT)
Status: Withdrawn Condition: Chronic Obstructive Pulmonary Disease; COPD; Chronic Bronchitis; Emphysema

Bronchoprotective Effect of Arformoterol in Children With Exercise-Induced Bronchospasm (EIB)
Status: Terminated Condition: Exercise-induced Bronchospasm

Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography
Status: Recruiting Condition: Chronic Obstructive Pulmonary Disease; COPD; Emphysema; Chronic Bronchitis

A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Status: Completed Condition: COPD

Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)
Status: Completed Condition: Chronic Obstructive Pulmonary Disease; Bronchitis; Emphysema

Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Status: Completed Condition: Chronic Obstructive Pulmonary Disease; Bronchitis; Emphysema

A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
Status: Completed Condition: Asthma

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion
BROVANA
arformoterol tartrate
SOLUTION;INHALATION021912Oct 6, 2006RXYes7,462,645<disabled><disabled>
Sunovion
BROVANA
arformoterol tartrate
SOLUTION;INHALATION021912Oct 6, 2006RXYes6,472,563<disabled>Y<disabled>
Sunovion
BROVANA
arformoterol tartrate
SOLUTION;INHALATION021912Oct 6, 2006RXYes6,589,508<disabled><disabled>
Sunovion
BROVANA
arformoterol tartrate
SOLUTION;INHALATION021912Oct 6, 2006RXYes6,720,453<disabled>Y<disabled>
Sunovion
BROVANA
arformoterol tartrate
SOLUTION;INHALATION021912Oct 6, 2006RXYes7,145,036<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: BROVANA

Drugname Dosage Strength RLD Submissiondate
arformoterol tartrateInhalation SolutionEq. 0.015 mg base/2 mLBrovana10/1/2009
« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc